Gilead Sciences Breaks Out To Record Highs, The Rally Has Room To Run

Discover why Gilead Sciences (GILD) is a top healthcare stock in 2025 with strong fundamentals and growth potential.

Bank of America Securities Remains a Buy on Gilead Sciences (GILD)

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.
News24

What’s in City Press: KT Molefe’s company still scoring big | Ramaphosa admits expropriation act is flawed

President Cyril Ramaphosa has acknowledged in court papers that article 19 of the controversial Expropriation Act creates a ...

Nurix Therapeutics Reports New Clinical Data from First-in-Class Oral CBL-B Inhibitor, NX-1607, Demonstrating Single-Agent Activity Across Multiple Tumor Types at the European ...

NX-1607 demonstrated on-target peripheral immune activation characteristic of an active immune-oncology agent with a novel immune checkpoint ...
MyChesCo on MSN

Unite for HER and TOUCHBBCA Expand Care for Black Breast Cancer Patients With 2025 Program

Unite for HER and TOUCH, The Black Breast Cancer Alliance (TOUCHBBCA), have announced the 2025 Care for HER program, an ...